Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens

References

1. Cohen M. L. Epidemiology of drug resistance: implications for a postantimicrobial era. Science 1992; 257:1050–1055
   [Google Scholar]
2. Neu H. C. The crisis of antibiotic resistance. Science 1992; 257:1064–1073
   [Google Scholar]
3. Kucers A., Bennet N. M. c. K. Rifampicin (Rifampicin). In: The use of antibiotics. A comprehensive review with clinical emphasis. 3rd edn London: William Heinemann; 1979552–584
   [Google Scholar]
4. Spratt B. G. Resistance to antibiotics mediated by target alterations. Science 1994; 264:388–393
   [Google Scholar]
5. Severinov K., Soushko M., Goldfarb A., Nikiforov V. Rifampicin region revisited: new rifampicin-resistant and streptolydigin-resistant mutants in the β-subunit of Escherichia coli RNA polymerase. J Biol Chem 1993; 268:14820–14825
   [Google Scholar]
6. Hui J., Gordon N., Kajioka R. Permeability barrier to rifampicin in mycobacteria. Antimicrob Agents Chemother 1977; 11:773–779
   [Google Scholar]
7. Cohen S. P., Yan W., Levy S. B. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J Infect Dis 1993; 168:484–488
   [Google Scholar]
8. Chandrasekaran S., Lalithakumari D. Plasmid-assisted morpholine degradation by Pseudomonas fluorescens CAS 102. World J Microbiol Biotechnol 1997 (in press)
   [Google Scholar]
9. Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1982
   [Google Scholar]
10. Berry D., Kropinski A. M. Effect of lipopolysaccharide mutations and temperature on plasmid transformation efficiency in Pseudomonas aeruginosa. Can J Microbiol 1986; 32:436–438
    [Google Scholar]
11. Nikaido H., Rosenberg E. Y. Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with β-lactam antibiotics containing catechol and analogous groups. J Bacteriol 1990; 172:1361–1367
    [Google Scholar]
12. Nikaido H. Outer membrane of Salmonella typhimurium: transmembrane diffusion of some hydrophobic substances. Biochim Biophys Acta 1976; 433:118–132
    [Google Scholar]
13. Cohen S. P., McMurry L. M., Levy S. B. mar A locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol 1988; 170:5416–5422
    [Google Scholar]
14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 1970; 227:680–685
    [Google Scholar]
15. Nesterenko M. V., Tilley M., Upton S. J. A simple modification of Blum’s silver stain method allows for 30 minute detection of proteins in polyacrylamide gels. J Biochem Biophys Methods 1994; 28:239–242
    [Google Scholar]
16. Abadi F. J. R., Carter P. E., Cash P., Pennington T. H. Rifampicin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob Agents Chemother 1996; 40:646–651
    [Google Scholar]
17. Fukuda H., Hosaka M., Hirai K., Iyobe S. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 1990; 34:1757–1761
    [Google Scholar]
18. Hirai K., Suzue S., Irikua T., Iyobe S., Mitsuhashi S. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1987; 31:582–586
    [Google Scholar]
19. Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993; 175:7363–7372
    [Google Scholar]
20. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994; 264:382–388
    [Google Scholar]
21. Grinius L. L., Goldberg E. B. Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump. J Biol Chem 1994; 269:29998–30004
    [Google Scholar]
22. Paulsen I. T., Brown M. H., Skurray R. A. Proton-dependent multidrug efflux systems. Microbiol Rev 1996; 60:575–608
    [Google Scholar]